Ospedale Santa Maria Goretti

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Atrial fibrillation1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Neuroendocrine tumours1 trial
• Obesity1 trial
• Pancreatic cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• CoreAalst BV1 trial
• Hospital Universitario 12 de Octubre1 trial
• Italian Association Neuroendocrine Tumors1 trial
• University Hospital of Ferrara1 trial

Running trials

• Recruiting

  Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)

  NCT06698159· Hospital Universitario 12 de Octubre· Source

  Contact: Daniel Rodríguez Muñoz, MD PhD

• Active, not recruiting

  Functional Coronary Angiography Guided Revascularization in STEMI

  NCT05818475· University Hospital of Ferrara· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· Phase 3· Eli Lilly and Company· Source

• Recruiting

  INSIGHTFUL-FFR Clinical Trial

  NCT05437900· Phase 4· CoreAalst BV· Source

  Contact: Iginio Colaiori, MD

• Recruiting

  Protocol ITANET - Registry

  NCT04282083· Italian Association Neuroendocrine Tumors· Source

  Contact: Chiara Spoto

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Coronary artery disease1 recruiting
• Neuroendocrine tumours1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

  NCT04166773· Phase 2· Eli Lilly and Company· Source